Evidence map›Paper›PMID 33129792›Full record

ArticleChest2021

Characteristics of Cardiac Injury in Critically Ill Patients With Coronavirus Disease 2019.

Denis Doyen, Pierre Dupland, Lucas Morand, Etienne Fourrier, Clément Saccheri, Matthieu Buscot, Hervé Hyvernat, Emile Ferrari, Gilles Bernardin, Alain Cariou and 4 more

Abstract read
In one paragraph

Article in Chest, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Echocardiographic assessment of the right ventricle in COVID-19: a systematic review.The international journal of cardiovascular imaging · 2021
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients.Translational research : the journal of laboratory and clinical medicine · 2021
    Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Multimodality Cardiac Imaging in COVID.Circulation research · 2023
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Denis DoyenService de Médecine Intensive Réanimation, Hôpital Archet 1, Centre Hospitalier Universitaire de Nice, Nice; Service de Cardiologie, Hôpital Pasteur, Centre Hospitalier Universitaire de Nice, Nice; Equipe 2 CARRES, UR2CA-Unité de Recherche Clinique Côte d'Azur, Université Côte d'Azur UCA, Nice. Electronic address: doyen.d@chu-nice.fr.
Pierre DuplandMédecine Intensive Réanimation, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Centre, Paris, France; Université de Paris, Paris, France.
Lucas MorandService de Médecine Intensive Réanimation, Hôpital Archet 1, Centre Hospitalier Universitaire de Nice, Nice.
Etienne FourrierService de Cardiologie, Hôpital Pasteur, Centre Hospitalier Universitaire de Nice, Nice.
Clément SaccheriService de Médecine Intensive Réanimation, Hôpital Archet 1, Centre Hospitalier Universitaire de Nice, Nice.
Matthieu BuscotService de Médecine Intensive Réanimation, Hôpital Archet 1, Centre Hospitalier Universitaire de Nice, Nice.
Hervé HyvernatService de Médecine Intensive Réanimation, Hôpital Archet 1, Centre Hospitalier Universitaire de Nice, Nice; Service de Cardiologie, Hôpital Pasteur, Centre Hospitalier Universitaire de Nice, Nice; Equipe 2 CARRES, UR2CA-Unité de Recherche Clinique Côte d'Azur, Université Côte d'Azur UCA, Nice.
Emile FerrariService de Cardiologie, Hôpital Pasteur, Centre Hospitalier Universitaire de Nice, Nice.
Gilles BernardinService de Médecine Intensive Réanimation, Hôpital Archet 1, Centre Hospitalier Universitaire de Nice, Nice; Equipe 2 CARRES, UR2CA-Unité de Recherche Clinique Côte d'Azur, Université Côte d'Azur UCA, Nice.
Alain CariouMédecine Intensive Réanimation, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Centre, Paris, France; Université de Paris, Paris, France.
Jean-Paul MiraMédecine Intensive Réanimation, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Centre, Paris, France; Université de Paris, Paris, France.
Matthieu JammeService de Réanimation Polyvalente, Centre Hospitalier Intercommunal de Poissy Saint Germain en Laye (CHIPS), Poissy; INSERM U1018, Centre de Recherche en Épidémiologie et Santé des Populations (CESP), Equipe "Epidémiologie Clinique," Université Paris Saclay, Villejuif, France.
Jean DellamonicaService de Médecine Intensive Réanimation, Hôpital Archet 1, Centre Hospitalier Universitaire de Nice, Nice; Equipe 2 CARRES, UR2CA-Unité de Recherche Clinique Côte d'Azur, Université Côte d'Azur UCA, Nice.
Mathieu JozwiakMédecine Intensive Réanimation, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Centre, Paris, France; Université de Paris, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiac injury has been reported in up to 30% of coronavirus disease 2019 (COVID-19) patients. However, cardiac injury is defined mainly by troponin elevation without description of associated structural abnormalities and its time course has not been studied. RESEARCH QUESTION: What are the ECG and echocardiographic abnormalities as well as their time course in critically ill COVID-19 patients? STUDY DESIGN AND

methodsThe cardiac function of 43 consecutive COVID-19 patients admitted to two ICUs was assessed prospectively and repeatedly, combining ECG, cardiac biomarker, and transthoracic echocardiographic analyses from ICU admission to ICU discharge or death or to a maximum follow-up of 14 days. Cardiac injury was defined by troponin elevation and newly diagnosed ECG or echocardiographic abnormalities, or both.

resultsAt baseline, 49% of patients demonstrated a cardiac injury, and 70% of patients experienced cardiac injury within the first 14 days of ICU stay, with a median time of occurrence of 3 days (range, 0-7 days). The most frequent abnormalities were ECG or echocardiographic signs, or both, of left ventricular (LV) abnormalities (87% of patients with cardiac injury), right ventricular (RV) systolic dysfunction (47%), pericardial effusion (43%), new-onset atrial arrhythmias (33%), LV relaxation impairment (33%), and LV systolic dysfunction (13%). Between baseline and day 14, the incidence of pericardial effusion and of new-onset atrial arrhythmias increased and the incidence of ECG or echocardiographic signs, or both, of LV abnormalities as well as the incidence of LV relaxation impairment remained stable, whereas the incidence of RV and LV systolic dysfunction decreased.

interpretationCardiac injury is common and early in critically ill COVID-19 patients. ECG or echocardiographic signs, or both, of LV abnormalities were the most frequent abnormalities, and patients with cardiac injury experienced more RV than LV systolic dysfunction.

Indexed as

COVID-19Heart DiseasesVentricular Dysfunction, LeftBiomarkersCritical IllnessEchocardiographyElectrocardiographyFemaleFranceHumansIncidenceIntensive Care UnitsMaleMiddle AgedSARS-CoV-2TroponinBiomarkersTroponincardiac injuryCOVID-19ECGechocardiographyICU

Identifiers

PMID33129792
PMCPMC7591864

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.